Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

VERNALIS PLC (VER)

0
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Vernalis Plc is a research and development stage pharmaceutical company.The company provides pharmaceutical products for a range of medical disorders.It focuses on de novo fragment and structure based drug discovery and pre clinical and clinical development.The group has one marketed product,... 
Surperformance© rating of Vernalis plc
Trading Rating : Investor Rating :
More about the company
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 10,7 M
EBIT 2014 -11,7 M
Net income 2014 -10,7 M
Finance 2014 30,8 M
Yield 2014 -
Sales 2015 13,8 M
EBIT 2015 -17,0 M
Net income 2015 -16,4 M
Finance 2015 20,2 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 17,7x
EV / Sales 2015 14,4x
Capitalization 219 M
More Financials
Latest news on VERNALIS PLC
7d ago VERNALIS : FDA accepts Tuzistra™ XR CCP-01 NDA for full review
09/16 VERNALIS : FDA accepts Tuzistra XR (CCP-01) NDA for full review
09/15 VERNALIS : Says Tuzistra Gets US New Drug Application Confirmation
09/15 VERNALIS : *canaccord raises vernalis plc price target to 56 (54) pence - 'buy'
09/15 VERNALIS : FDA accepts TuzistraTM XR NDA for full review
09/15 VERNALIS : Announces FDA Accepts Tuzistra(TM) XR NDA for Full Review
08/14 VERNALIS : *canaccord raises vernalis plc price target to 54 (52) pence - 'buy'
08/07 VERNALIS : and Servier achieve two Research Milestones in their Oncology Collabo..
08/05 VERNALIS : Swings To First-Half Loss On Sterling Strength
08/05 VERNALIS : Interim results for six months ended 30 June 2014
08/05 VERNALIS : Interim results for the six months ended 30 June 2014
08/04 VERNALIS : Paid EUR750,000 As Servier Collaboration Reaches Milestones
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF